Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Enpatoran by Merck for Systemic Lupus Erythematosus: Likelihood of Approval
Enpatoran is under clinical development by Merck and currently in Phase II for Systemic Lupus Erythematosus. According to GlobalData, Phase...
Enpatoran by Merck for Subacute Cutaneous Lupus Erythematosus (SCLE): Likelihood of Approval
Enpatoran is under clinical development by Merck and currently in Phase II for Subacute Cutaneous Lupus Erythematosus (SCLE). According to...
Enpatoran by Merck for Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE): Likelihood of Approval
Enpatoran is under clinical development by Merck and currently in Phase II for Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid...
Enpatoran by Merck for Cutaneous Lupus Erythematosus: Likelihood of Approval
Enpatoran is under clinical development by Merck and currently in Phase II for Cutaneous Lupus Erythematosus. According to GlobalData, Phase...